SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

β-HCG Rapid Quantitative Test

β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.

TT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)

TT3 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Total Triiodothyronine (TT3) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

MAU Rapid Quantitative Test

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

Cys-C Rapid Quantitative Test

Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A